CompletedNot applicableNCT03095339

EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso

Studying Cysticercosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Oklahoma
Principal Investigator: Hélène Carabin, DVM PhD
University of Oklahoma
Intervention: Educational package(other)
Enrollment: 58 enrolled
Eligibility: 5 years · All sexes
Timeline: 2011 – 2015

Study locations (1)

AFRICSanté, Bobo-Dioulasso, Burkina Faso

Collaborators

AFRICSanté · Institute of Tropical Medicine, Belgium · Institut de Recherche en Sciences de la Sante, Burkina Faso · University of Ouagadougou, Burkina Faso · University Hospital, Limoges · Centre Universitaire Souro Sanou · Technical University of Munich · Brown University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03095339 on ClinicalTrials.gov

Other trials for Cysticercosis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00001205
Natural History of Treated Neurocysticercosis and Long-Term Outcomes
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Cysticercosis →

← Back to all trials